What It Is Class: Cosmetic regenerative + calming peptide blend Components: 50mg GHK-Cu, 10mg BPC-157, 10mg TB-500, 10mg KPV Concept: Multi-pathway topical or localized injectable peptide formulation targeting skin repair, elasticity, hydration, follicle health, and comfort-focused recovery signaling Proposed Mechanisms (Preclinical) Skin & ECM Remodeling GHK-Cu (50mg): Stimulates collagen, elastin, and glycosaminoglycan production in dermal fibroblasts Reduces inflammation and promotes angiogenesis via copper-mediated pathways Improves skin firmness, hydration, and tone in cosmetic and preclinical models Tissue Repair & Regeneration BPC-157 (10mg): Supports localized wound healing, microvascular integrity, and fibroblast migration TB-500 (10mg): Modulates actin-binding proteins involved in cellular repair and tissue regeneration Synergistic effect in mesotherapy or microneedling for accelerated skin healing and anti-aging support Calm & Comfort Signaling KPV (10mg): Studied in preclinical models for modulating irritation-associated and inflammation signaling pathways Often included in cosmetic protocols targeting post-stressor comfort, barrier support, and redness-prone skin research Selected Research Highlights Skin Rejuvenation: Explored in protocols to support skin density, texture refinement, and dermal remodeling Calm/Barrier Support: Investigated in cosmetic models for comfort-focused outcomes, redness-prone skin response, and post-procedure recovery signaling Hair & Scalp Health: Studied in cosmetic protocols for follicle signaling, hair thickness support, and scalp circulation Post-Procedure Recovery: May support balanced recovery response following microneedling, RF, laser resurfacing, or dermabrasion Chemical & Handling Information Type: Lyophilized cosmetic peptide blend Appearance: Blue to blue-green powder (color varies with copper content) Specifications Peptide: KLOW (GHK-Cu 50mg, BPC-157 10mg, TB-500 10mg, KPV 10mg) Amount: 80 mg per vial Form: Lyophilized powder Purity: 99% (HPLC)

In the meantime, mitochondrial dysfunction is induced by hepatic IR and lipid accumulation and the lipid peroxidation mediated by cytochrome p450 2E1 boost the production of reactive oxygen and promote the degradation of mitochondria (125), which could further lead to the lack of cellular energy and metabolic intermediates accumulation, all these may lead to the secretion of pro-inflammatory cytokines, hepatocellular apoptosis and hepatic fibrogenesis, finally resulting in cirrhosis of the liver (125) ( Figure 3 )
Composition Pre-formulated liquid solution Total concentration: 196mg/mL 10mL vial L-Carnitine 20mg/mL L-Arginine 20mg/mL L-Methionine 25mg/mL Inositol 50mg/mL Choline Chloride 50mg/mL Pyridoxine HCl (B6) 25mg/mL Calcium Pantothenate (B5) 5mg/mL Cyanocobalamin (B12) 1mg/mL Appearance: Fully constituted liquid solution in a sealed 10 mL research vial Storage: Keep out of light, tightly closed, dry
As doses increase, some side effects may return, but with monitoring and care, they can be managed, he adds